Our findings suggest that the role of MAP9 in normal retinal function warrants further investigation, including functional assessment of MAP9 protein as well as screening for MAP9 variants in IRDs patients whose underlying genetic variants have not been accounted for, particularly if there are indications of ciliopathy. This evidence concerns the gene MAP9 and ciliopathy.